Disclaimer: EMA by AIVF has CE mark. In the US, an AI component of EMA is considered an investigational device. Limited by Federal (or United States) law to investigational use.
©All rights reserved AIVF 2023
Single news top News top bg mobile 2

The Digital Health 50: The most promising digital health companies of 2023

CB Insights | Dec 19, 2023
The Digital Health 50 is CB Insights’ annual ranking of the 50 most promising digital health startups in the world. This year's winners are working on making healthcare AI safer, developing new drugs and therapies, bringing clinical trials to underserved populations, and more.

AIVF was selected by  CB Insights to be included in the exclusive 50 Most Promising Digital Health Companies of 2023, Clinical Intelligence category. A huge honor for us!